RxDoctor Payments Data

Leah Bennett

Physician Assistant · Aberdeen, SDNPI 1902332760

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,994 of the $4,542 with a category attached, or 87.9%. It is spread thinly across 19 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,542in general payments, 2019–2025

Across 204 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$977
  • Regeneron Healthcare Solutions, Inc.$743
  • Johnson & Johnson$692
  • Sanofi$407
  • Lilly USA, LLC$323
  • UCB, Inc.$299
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,99488%
  • Education$54812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,542 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$86,195
Medicare patients
554
Services billed
3,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab17$142,434
Taltz AutoinjectorIxekizumab13$79,511
OtezlaApremilast12$52,034
Fluorouracil42$3,500
Clobetasol Propionate52$3,000
Triamcinolone Acetonide50$2,124
Ketoconazole66$1,438
Tacrolimus12$1,083
Clindamycin Phosphate26$983
Fluocinonide14$897
Metronidazole18$677
Econazole Nitrate13$480
Doxycycline Hyclate17$351
Desonide11$346
ValacyclovirValacyclovir Hcl13$212

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$222$52,03412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Aberdeen

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →